Aurora Cannabis Inc

Most Recent

  • uploads///Aphrias Short Interest
    Company & Industry Overviews

    Gauging the Bullish-Bearish Sentiment on Aphria

    The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.

    By Adam Jones
  • uploads///Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    Do CGC, ACB, TLRY, and APHA Look Cheap?

    With the exception of Aphria, Tilray, Canopy Growth, and Aurora Cannabis were trading at a premium to the peer median EV-to-EBITDA multiple.

    By Adam Jones
  • uploads///Uhhled
    Earnings Report

    Cronos Group Invests in the Future

    Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.

    By Adam Jones
  • uploads///seedling _
    Company & Industry Overviews

    ACB, APHA, CTST, and HEXO Fall on March 20

    The Horizons Marijuana Life Sciences ETF (HMMJ) had fallen by about 1.2% as of noon on March 20, while the ETFMG Alternative Harvest ETF (MJ) had declined by nearly 0.8%.

    By Adam Jones
  • uploads///Gross Income and EBITDA Estimates
    Miscellaneous

    Aurora Cannabis: Analysts’ Projections

    Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.

    By Adam Jones
  • uploads///
    Company & Industry Overviews

    Checking On Canopy Growth and Its Peers

    Canopy Growth is one of the strongest players in the cannabis industry with a market cap of ~24 billion Canadian dollars.

    By Adam Jones
  • uploads///Forward EV to Sales
    Miscellaneous

    Does Cronos Group Look Expensive Compared to Its Peers?

    Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.

    By Adam Jones
  • uploads///cannabis
    Cannabis

    Marijuana Movement: Why Do Celebrities Support It?

    Marijuana is gaining more and more attention. What’s caught the most attention is that many celebrities are joining the growing support movement.

    By Sushree Mohanty
  • uploads///marijuana _
    Company & Industry Overviews

    Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’

    Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.

    By Adam Jones
  • uploads///Trump
    Cannabis

    What Does President Trump Think about Marijuana?

    President Trump hasn’t directly supported or opposed marijuana. In the past, he said that marijuana makes people “lose IQ points.”

    By Sushree Mohanty
  • uploads///cannabis _
    Miscellaneous

    Canaccord Genuity Raises Price Target for Canopy Growth

    On February 18, Canopy Growth (WEED) received a price target upgrade from Canaccord Genuity.

    By Adam Jones
  • uploads///AdobeStock_
    Company & Industry Overviews

    Top Developments in the Cannabis Industry’s Early Years

    In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.

    By Adam Jones
  • uploads///Vaping
    Cannabis

    Why Vaping May Not Be a Gold Mine for Cannabis Players

    In recent years, vaping devices or e-cigarettes have been considered safer than tobacco cigarettes. However, the rise in vaping is now a matter of concern.

    By Sirisha Bhogaraju
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis’s Revenue: Here’s What Analysts Expect

    Aurora Cannabis is set to release its fiscal 2020 first-quarter earnings results on November 11. Let’s see what analysts expect for its upcoming quarter.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Aurora Cannabis’s Price Target Cut by 30%

    Aurora Cannabis (ACB) stock is currently down 29.23% on the NYSE on a YTD (year-to-date) basis. The company has lost 14.81% of its value since October 1.

    By Margaret Patrick
  • uploads///marijuana
    Cannabis

    Marijuana Policy: Can California Shape It for the US?

    Marijuana reform has always been important in California, which became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Marijuana to Treat New Conditions in Minnesota

    In August 2020, chronic pain and age-related macular degeneration would be eligible for treatment under Minnesota’s medical marijuana program.

    By Margaret Patrick
  • uploads///can_
    Cannabis

    Cannabis Legalization: Four Governors Met in New York

    The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.

    By Rajiv Nanjapla
  • uploads///pot stocks
    Cannabis

    Cannabis Investment: How to Buy ACB, CGC, and Other Stocks

    Cannabis is a hot sector that’s constantly evolving. Right now, how to buy cannabis stocks is a question that’s likely on many investors’ minds.

    By Sushree Mohanty
  • uploads///c
    Miscellaneous

    Canopy Growth Receives Target Price Upgrades

    Cormark Securities raised its target price for Canopy Growth to 40 Canadian dollars from 33 Canadian dollars, which represents an increase of almost 21%.

    By Adam Jones
  • uploads///Cannabis
    Cannabis

    Cannabis in Mexico: Legalization Bill Is Ready for Voting!

    Cannabis legalization is approaching the deadline in Mexico. According to the Supreme Court, the deadline for marijuana legalization is Wednesday.

    By Sushree Mohanty
  • uploads///Mexico
    Cannabis

    Mexico Will Attempt to Legalize Marijuana in 2020

    Mexico is ready with a revised proposal to legalize marijuana this year. The Supreme Court gave lawmakers until April 30 to submit the new proposal.

    By Sushree Mohanty
  • uploads///green _
    Company & Industry Overviews

    Tilray Invests in ROSE LifeScience

    On December 14, Tilray (TLRY) announced that it’s investing in ROSE LifeScience—a cannabis producer in Quebec.

    By Adam Jones
  • uploads///cannabis _
    Company & Industry Overviews

    Revisiting Valuation Multiples for Cannabis Companies

    Recreational cannabis is close to being legalized in Canada, and producers are running at full bore to capture a piece of the market.

    By Adam Jones
  • uploads///hexo
    Cannabis

    HEXO: Analysts’ Target Price and Ratings

    CIBC downgraded HEXO to “neutral” from “outperform” and reduced the target price to 8.5 Canadian dollars from 9.5 Canadian dollars.

    By Sushree Mohanty
  • uploads///hemp _
    Company & Industry Overviews

    Cannabis Sector Closes Positively in the Week Ended April 13

    Last week (ended April 13), overall market sentiment was positive, with the S&P 500 rising 2% and the TSX 30 gaining 44 basis points.

    By Adam Jones
  • uploads///canopy
    Consumer

    Canopy Growth Stock Rises, Oppenheimer Initiates Coverage

    Oppenheimer analyst Rupesh Parikh initiated coverage on Canopy Growth stock. The analyst gave a “perform” rating with no target price.

    By Sushree Mohanty
  • uploads///Can_
    Cannabis

    What Do Analysts Recommend for Canopy Growth?

    On December 16, Canopy Growth was trading at 26.79 Canadian dollars, implying a rise of 9.6% since its fiscal 2020 second-quarter earnings release.

    By Rajiv Nanjapla
  • uploads///Canopy_
    Cannabis

    Can Canopy Beat Q2 Estimates and Boost the Sector?

    This week is important for the cannabis sector, as Canopy Growth and Aurora Cannabis are both set to report their earnings results on November 14.

    By Rajiv Nanjapla
  • uploads///Cronos group
    Cannabis

    Cronos Group Joins Altria to Bet on Cannabidiol Market

    Cannabis company Cronos Group has expanded its presence in the US cannabidiol market through a tie-up with tobacco company Altria Group.

    By Sushree Mohanty
  • uploads///mariju
    Cannabis

    Marijuana Vape Products Expected in Alberta Stores

    AGLC will allow retail stores in Alberta to sell marijuana vape products. Consumers will likely be able to purchase cannabis vape products in the next two weeks.

    By Rajiv Nanjapla
  • uploads///arnel hasanovic oWSXdeASg unsplash
    Cannabis

    Why Canopy Growth Isn’t Happy with Apple

    Apple removed 181 vaping-related apps due to the vape crisis in the US. Canopy Growth is not happy with Apple’s move. Let’s see why.

    By Sushree Mohanty
  • uploads///aurora cannabis
    Cannabis

    Aurora Cannabis: What to Expect from Its Q4 Results

    Aurora Cannabis should report its fourth-quarter earnings results on Thursday. So far, September has been positive. As of Monday, the stock has gained 8.7%.

    By Sushree Mohanty
  • uploads///south dakota cannabis
    Cannabis

    South Dakota Plans for Marijuana Legalization amid COVID-19

    Marijuana is illegal in South Dakota. However, the state decided to make both recreational and medical marijuana legal this year.

    By Sushree Mohanty
  • Cannabis

    Marijuana Legalization Continues: Wisconsin Steps Up!

    Marijuana laws are pretty strict in Wisconsin. Although cannabis is spreading its roots across US states, it’s still illegal at the federal level. President Trump and his administration want states to decide. Florida, New York, and Minnesota are all gearing up to legalize adult-use cannabis. Now, Wisconsin is pushing to legalize medical marijuana. Let’s see […]

    By Adam Jones
  • uploads///Aphria
    Cannabis

    Is Aphria a Good Cannabis Pick for 2020?

    Aphria has successfully strengthened its position not only in Canada but also in international markets. The company reported impressive second-quarter results.

    By Sushree Mohanty
  • uploads///medmen upcoming results
    Cannabis

    Will MedMen Deliver Any Good News in Its Q2 Earnings?

    MedMen will report its earnings results for the second quarter of fiscal 2020 on Wednesday. Analysts expect 67.6% YoY revenue growth.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis 2.0: Aphria Gets Ready for Edibles Market

    Cannabis 2.0 legalization will take place in Canada this month. Aphria plans to expand its consumer base in the vape and concentrates business.

    By Sushree Mohanty
  • uploads///marijuana hashish leaf flowerpot
    Cannabis

    Big News: Cannabis Edibles in Alberta Stores

    Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.

    By Rajiv Nanjapla
  • uploads///trump
    Cannabis

    Elizabeth Warren Unveils Plan for Marijuana Legalization

    According to Warren’s new marijuana plan, the federal legalization process would start within 100 days of her taking office.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Medical Marijuana Is Booming in OK, Struggles in OH

    Medical marijuana is a hit in Ohio since it allowed it in 2016. Recreational cannabis is still not allowed. Notably, data has shown that Ohio’s medical cannabis industry is booming since it started in 2019. However, the medical cannabis industry is facing some setbacks as well. So, let’s take a look at it. Ohio and […]

    By Sushree Mohanty
  • uploads///california marijuana future
    Cannabis

    Marijuana Industry: Opportunities in California amid COVID-19

    Marijuana is an old but growing market in California. Notably, California became the first state to legalize medical marijuana in 1996.

    By Sushree Mohanty
  • uploads///Medical cannabis
    Cannabis

    Medical Cannabis in Brazil Is Coming

    According to a Reuters report on December 3, Brazil is ready to approve medical cannabis products. Currently, cannabis is illegal in Brazil.

    By Sushree Mohanty
  • uploads///Cannabis
    Cannabis

    Cannabis Sector 2019 Review and 2020 Outlook

    Canada legalized cannabis in October 2018, so investors expected 2019 to drive marijuana sales. However, the fate of the industry took a sharp turn.

    By Sushree Mohanty
  • uploads///cannabis _
    Cannabis

    How Cannabis Stocks Fared Last Week

    Tilray was the top performer in the cannabis sector last week with a rise of 49% as a result of better-than-expected second-quarter earnings and guidance.

    By Adam Jones
  • uploads///marijuana
    Cannabis

    Marijuana: Will Trump Have an Edge over Biden?

    With Biden strongly opposing full-scale legalization, President Trump could turn around things. President Trump might support medical marijuana legalization.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Miscellaneous

    Aurora Cannabis: Analysts’ Target Price after Its Earnings

    Aurora Cannabis (ACB) reported its fourth-quarter results on September 11. The results disappointed analysts and investors.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    CBD: Japan Welcomes NBEV, Stock Pops

    Today, New Age Beverages Corporation (NBEV) announced that it would launch its CBD (cannabidiol) based products. Share prices jumped by 14.96% to $3.20.

    By Margaret Patrick
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: O’Rourke Blazes His 2020 Campaign

    Democratic presidential candidate Beto O’Rourke is known for voicing his opinion on federal marijuana legalization. He supports marijuana legalization.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: South Dakota Does What Trump Said!

    Marijuana legalization is ramping up. Now, South Dakota is taking President Trump’s advice. The state is kicking off a petition to legalize cannabis.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Aphria: Why Jefferies Recommends a ‘Buy’

    Aphria (APHA) reported its results for the first quarter of fiscal 2020 on October 15. Since then, the stock has fallen 7%.

    By Sushree Mohanty
  • uploads///Canopy
    Cannabis

    Canopy Gets Estimates Revised by Analysts for 2020

    Canopy Growth (CGC) (WEED) missed analysts’ estimates this year. Analysts had huge expectations from CGC after Canada allowed cannabis in 2018.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray: Are Analysts Optimistic about Its Stock?

    After Tilray’s second-quarter earnings, Benchmark reduced its target price to $80 from $120. Cowen and Company reduced the target price to $60 from $150.

    By Sushree Mohanty
  • uploads///
    Cannabis

    Cannabis Roundup: HEXO, WEED, ACB, and CTST

    The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis in Kansas: Residents Are Taking Action

    Currently, 33 states and Washington, D.C., have legalized medical cannabis, but it’s illegal in Kansas. Even having a small amount is considered a crime.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Stock and Peers Are Struggling

    Aurora Cannabis (ACB) had a hard time this year. ACB stock had been investors’ favorite in 2018. The stock started off 2019 on a good note

    By Sushree Mohanty
  • uploads///Canopy Growth Stock on March
    Company & Industry Overviews

    Why Alcaliber Makes Sense for Canopy Growth

    On March 6, Bloomberg Markets reported that Canopy Growth (WEED) put in a bid for privately held Spanish company Alcaliber.

    By Adam Jones
  • uploads///canopy growth pi financial
    Cannabis

    Canopy Growth: Why PI Financial Suggests a ‘Sell’

    Canopy Growth dragged its stock down after its unimpressive end to fiscal 2020. The company missed the revenue estimates by a huge margin.

    By Sushree Mohanty
  • uploads///Joe Biden
    Cannabis

    Joe Biden Won’t Legalize Cannabis—Why?

    Although Joe Biden supported medical cannabis in his previous presidential campaigns, he has always opposed full-scale legalization.

    By Sushree Mohanty
  • uploads///cannabis _
    Company & Industry Overviews

    Canada’s Cannabis Act C-45 Makes Progress in the Senate

    On May 28, Bill C-45, Canada’s recreational cannabis legalization bill, saw further progress in the Senate.

    By Adam Jones
  • uploads///texas
    Cannabis

    Marijuana in Texas: Five Things You Should Know

    Marijuana laws are pretty strict in Texas, but could this change? Here are five things you need to know about the state’s relationship with marijuana.

    By Sushree Mohanty
  • uploads///Canopy Growth Analysts NTM Recommendations and Targets
    Miscellaneous

    Price Target Update for Canopy Growth in January

    Canopy Growth (WEED) (CGC) has continued to deepen its roots in the United States with a recent announcement that could be a game changer.

    By Adam Jones
  • uploads///matthias wagner QrqeusbpFMM unsplash
    Cannabis

    Why Canopy Growth Is Partnering with Drake

    The Canadian Press reported that Canopy Growth is partnering with rapper Drake to launch a new cannabis venture, the More Life Growth Company.

    By Sushree Mohanty
  • uploads///AdobeStock_
    Cannabis

    Cannabis Sector: A Week in Review for Sept 20

    Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.

    By Adam Jones
  • uploads///KHC EPS
    Cannabis

    Key Takeaways on the SAFE Banking Act Hearing

    On Tuesday, the US Senate held a hearing on the SAFE (Secure and Fair Enforcement) Banking Act. On March 26, the House Committee passed the act. The act will need to pass the Senate before it is sent to the US president. If passed, the act would greatly help US cannabis businesses. What is the […]

    By Market Realist
  • uploads///cannabis stocks
    Cannabis

    Which Cannabis Stocks Have Lost More than 40% in 2019?

    The cannabis industry has been on a rollercoaster ride this year. CannTrust, Tilray, and KushCo stocks have fallen more than 40% in 2019.

    By Sushree Mohanty
  • uploads///cann
    Cannabis

    Cannabis Legalization: Is It Time for the US to Act?

    Cannabis legalization has America’s attention. A Gallup survey has shown that two-thirds of Americans want cannabis legalized now.

    By Sushree Mohanty
  • Cannabis

    Cannabis 2.0 Legalization: Canada Is Ready

    Federally, cannabis legalization saw daylight in Canada in 2018. The Cannabis Act legalized recreational marijuana in October 2018. Now, the country is all set for the second wave of legalization, Cannabis 2.0, which includes cannabis edibles, cannabis-infused beverages, extracts, and various other products. Let’s dig into this more. Canada’s second wave of legalization Next month, […]

    By Sushree Mohanty
  • uploads///marijuana _
    Company & Industry Overviews

    How Cannabis Companies Are Rushing to Expand Operations

    In anticipation of recreational cannabis’s legalization at the federal level in Canada, provinces have been doing their best to prepare.

    By Adam Jones
  • uploads///canopy growth buy q
    Cannabis

    Why Canopy Growth Is a ‘Buy’ before Its Earnings

    Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?

    By Rajiv Nanjapla
  • uploads///cannabis
    Cannabis

    Cannabis Beverages: Why Canadians Can’t Wait

    Deloitte estimates that the newly legalized cannabis beverage market could be worth 529 million Canadian dollars annually in Canada.

    By Sushree Mohanty
  • uploads///CGC_
    Cannabis

    Why Does Jim Cramer Prefer CGC versus CRON?

    Canopy Growth (NYSE:CGC) lost 25.4% in 2019. The company reported weak sales and higher-than-expected operating losses in the last two quarters.

    By Rajiv Nanjapla
  • uploads///cannabis edibles
    Cannabis

    No Cannabis Edibles in Three Provinces for Christmas

    After Canada legalized cannabis edibles in October, consumers hoped to buy these products this month. However, three provinces must wait until January.

    By Sushree Mohanty
  • uploads///cannabsis
    Cannabis

    Cannabis 2.0: Aurora Cannabis Gears Up for Edibles Market

    Cannabis 2.0 legalization will take place in Canada next month. Cannabis players are gearing up to expand in the edibles market.

    By Sushree Mohanty
  • uploads///marijuana _
    Company & Industry Overviews

    How Cannabis Stocks Performed Last Week

    Strong sentiment in the cannabis sector pushed cannabis ETFs and stocks into positive territory last week.

    By Adam Jones
  • uploads///ACB
    Cannabis

    Will Aurora Cannabis Turn the Corner in 2020?

    Despite being prepared after Canada legalized recreational cannabis in 2018, Aurora Cannabis struggled to hit its revenue numbers.

    By Sushree Mohanty
  • uploads///marijuana
    Cannabis

    Marijuana Campaigns Continue in Nebraska and Montana

    Nebraska needs to collect 130,000 valid signatures from registered voters by July 8 to qualify recreational marijuana legalization for the November 2020 ballot.

    By Sushree Mohanty
  • uploads///marijuana _
    Miscellaneous

    What Analysts Recommend for Cannabis Stocks in March

    Most of the major cannabis stocks are in the red on a year-to-date basis.

    By Adam Jones
  • uploads///Household Consumption Expenditure on Cannabis
    Company & Industry Overviews

    Why Cannabis Stocks Are on the Rise

    The reason cannabis stocks are rising could be because October 17 is approaching.

    By Adam Jones
  • uploads///AdobeStock_
    Cannabis

    Was CGC a Big Mistake for Constellation Brands?

    Canopy Growth (CGC) has seen dizzying ups and gloomy downs in 2019. The stock jumped up by 79.91% from $28.92 on January 2 to $52.03 on April 29.

    By Margaret Patrick
  • uploads///NAC Locations
    Company & Industry Overviews

    National Access Cannabis to Get Cannabis from CannaRoyalty

    Last week, National Access Cannabis signed a binding term sheet with CannaRoyalty (CRZ) to carry the latter’s products in its stores across Canada.

    By Adam Jones
  • uploads///weed _
    Earnings Report

    Aphria Reports Quarterly Loss, PI Financial Raises Price Target

    Aphria (APH) (APHQF) reported its fiscal 4Q 2018 earnings on August 1. It more than doubled its sales but had a net quarterly loss.

    By Adam Jones
  • uploads///Aurora Cannabis
    Cannabis

    Why Aurora Cannabis Wants to Grow Cannabis Outdoors

    Aurora Cannabis (ACB) wants to grow cannabis outdoors. In July, it received Health Canada licenses for outdoor cultivation at two Canadian sites.

    By Sushree Mohanty
  • uploads///marijuana covid
    Cannabis

    Could Certain Marijuana Strains Help Fight COVID-19?

    The cannabis industry is doing its own research amid COVID-19. Researchers discovered that marijuana might have properties to fight the coronavirus.

    By Sushree Mohanty
  • uploads/// Forward EV to EBITDA Multiple for Cannabis Companies
    Company & Industry Overviews

    How Aurora Cannabis’s Valuations Compare to Its Peers’

    On January 18, Canopy Growth was trading at an EV-to-EBITDA multiple of 110.9x.

    By Adam Jones
  • uploads///Aurora Cannabis
    Cannabis

    Is Aurora Cannabis Ready for Cannabis 3.0?

    Aurora Cannabis (ACB) is ready to launch its new products for Cannabis 2.0. But is the company ready for the next phase? Let’s find out.

    By Sushree Mohanty
  • uploads///cannabis
    Cannabis

    Cannabis Legalization: The World Waits for the US

    Cannabis legalization is spreading its roots globally. Considering that other countries are legalizing marijuana, will the US follow suit?

    By Sushree Mohanty
  • uploads///Canopy Growth
    Cannabis

    What’s Canopy Growth Strategy for Growth?

    Canopy Growth has struggled this year. Despite all their strategies, cannabis companies have failed to hit revenue and profitability targets this year.

    By Sushree Mohanty
  • uploads///IIPR
    Basic Materials

    IIPR, CRON, TLRY Surging: A Good Day for Cannabis Stocks

    It looks like cannabis stocks had a great day. Innovative Industrial Properties (IIPR), Cronos Group (CRON), and Tilray (TLRY) are all surging today.

    By Sushree Mohanty
  • uploads///arizona marijuana ballott
    Cannabis

    Arizona’s Marijuana Campaign Qualifies for November Ballot

    Marijuana campaigns in most US states faced challenges gathering enough signatures amid the pandemic. However, Arizona got plenty of signatures.

    By Sushree Mohanty
  • uploads///seedling _
    Company & Industry Overviews

    Canopy Growth Completes EBBU Acquisition

    Canopy Growth (WEED) (CGC) announced yesterday that it completed the previously announced acquisition of EBBU.

    By Adam Jones
  • uploads///marijuana
    Cannabis

    Marijuana Legalization: What’s Happening in Utah?

    Recreational cannabis isn’t legal in Utah. Although the state legalized medical cannabis in 2018, the medical marijuana program will go live in March 2020.

    By Sushree Mohanty
  • uploads///Aurora Cannabis
    Cannabis

    Aurora Cannabis: Is This the Right Time to Invest?

    Amid a subdued cannabis sector, Aurora Cannabis (ACB) stock has taken a serious hit and is down 36.4% this month. Is this the right time to invest?

    By Sushree Mohanty
  • uploads///illinois cannabis sales
    Cannabis

    Illinois’ Cannabis Sales Soared in June: Which Stocks Will Benefit?

    Cannabis sales have been soaring in all of the US states that classified it as an “essential item” amid the pandemic. Illinois has seen tremendous growth.

    By Sushree Mohanty
  • uploads///Tilray
    Cannabis

    Tilray’s Q2 Earnings Are Out: Did It Impress?

    In its Q2 earnings report today, Tilray reported a 371% YoY revenue increase to $45.9 million. Tilray beat analysts’ estimate of $41.1 million in revenue.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Has Irwin Simon Really Turned Aphria Around?

    Aphria (APHA) has impressed investors with its earnings results this year. Overall, the cannabis industry has struggled due to various headwinds.

    By Sushree Mohanty
  • uploads///TJX Sales
    Cannabis

    Aurora Cannabis: Target Price and Valuation Update

    So far, July has been rough for Aurora Cannabis (ACB). The stock has been trending lower ever since the beginning of the month. As of Thursday, the stock has fallen about 17%. However, the stock has delivered a positive return this year. Aurora Cannabis has delivered a positive return of 30% YTD (year-to-date). When we […]

    By Market Realist
  • uploads///Republicans
    Cannabis

    Do Republicans Want to Join the Cannabis Action?

    Republicans have been conservative about cannabis. However, cannabis legalization is a popular discussion topic among Democrats.

    By Sushree Mohanty
  • uploads///marijuana in june
    Cannabis

    Will Marijuana Stocks Continue to Surge in June?

    May was an earnings month for many marijuana companies. Notably, US companies showed better revenue growth than their Canadian peers.

    By Sushree Mohanty
  • uploads///Aphria
    Cannabis

    Aphria: Analysts’ Target Price and Ratings

    While Aphria’s consensus target price fell after its earnings, most analysts remain bullish on the stock. The overall “strong-buy” rating didn’t change.

    By Sushree Mohanty
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.